Breast Neoplasm
2 competing products in clinical development for Breast Neoplasm.
Pipeline by Phase
Phase 1/21
Phase 21
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Eribulin Mesylate + Pembrolizumab | Eisai | Phase 1/2 | Completed | 32 |
| Abemaciclib + Fulvestrant | Eli Lilly | Phase 2 | Terminated | 27 |